Currently, there are 215.21M common shares owned by the public and among those 183.50M shares have been available to trade.
The company’s stock has a 5-day price change of 27.29% and 22.12% over the past three months. HIMS shares are trading 114.89% year to date (YTD), with the 12-month market performance up to 320.73% higher. It has a 12-month low price of $12.07 and touched a high of $72.98 over the same period. HIMS has an average intraday trading volume of 34.72 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 49.75%, 53.57%, and 87.52% respectively.
Institutional ownership of Hims & Hers Health Inc (NYSE: HIMS) shares accounts for 71.66% of the company’s 215.21M shares outstanding.
It has a market capitalization of $11.63B and a beta (3y monthly) value of 1.90. The stock’s trailing 12-month PE ratio is 75.63, while the earnings-per-share (ttm) stands at $0.69. The company has a PEG of 2.25 and a Quick Ratio of 1.32 with the debt-to-equity ratio at 0.12. Price movements for the stock have been influenced by the stock’s volatility, which stands at 13.57% over the week and 10.05% over the month.
Earnings per share for the fiscal year are expected to increase by 21.81%, and 48.23% over the next financial year. EPS should grow at an annualized rate of 33.66% over the next five years, compared to 17.22% over the past 5-year period.
Looking at the support for the HIMS, a number of firms have released research notes about the stock. TD Cowen stated their Hold rating for the stock in a research note on April 29, 2025, with the firm’s price target at $30. Morgan Stanley coverage for the Hims & Hers Health Inc (HIMS) stock in a research note released on February 18, 2025 offered a Equal-Weight rating with a price target of $60. Citigroup was of a view on January 10, 2025 that the stock is Sell, while BTIG Research gave the stock Buy rating on January 07, 2025, issuing a price target of $35. Morgan Stanley on their part issued Overweight rating on December 17, 2024.
